Onesource Specialty Pharma P/E Ratio
Onesource Specialty Pharma P/E ratio. Onesource Specialty Pharma (ONESOURCE) P/E ratio is not applicable — EPS (TTM) ₹-6.44. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-6.44
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | 0.40 | 5 | Profit |
| Jun 2026 | 2.18 | 25 | Profit |
| Sept 2025 | 0.92 | 11 | Profit |
| Mar 2025 | 8.61 | 99 | Profit |
| Jun 2025 | -0.02 | 0 | Loss |
| Dec 2025 | -7.74 | -89 | Loss |
| Sept 2024 | -10.13 | -42 | Loss |
| Mar 2024 | -9.67 | -40 | Loss |
Healthcare Peers with Valid P/E Ratios — ONESOURCE Comparison
Healthcare sector average P/E 54.83, median 31.69 — ONESOURCE excluded (negative EPS).
Sector Average PE
54.83
Sector Median PE
31.69
Lowest PE
2.02
Profitable Companies
201
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.02 | ₹60 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.33 | ₹55 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.86 | ₹6,006 | Low |
| Dipna Pharmachem | DPL | 3.97 | ₹11 | Low |
| JFL Life Sciences | JFLLIFE | 5.05 | ₹65 | Low |
| Royal Sense | ROYAL | 5.39 | ₹40 | Low |
| Kabra Drugs | KABRADG | 5.47 | ₹41 | Low |
| GKB Ophthalmics | GKB | 5.85 | ₹32 | Low |
| Colinz Laboratories | COLINZ | 6.31 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Onesource Specialty Pharma share price today.
- Examine Onesource Specialty Pharma quarterly financials for recent quarterly revenue, profit and EPS trends.
- Also explore Onesource Specialty Pharma share price performance to track price trends across different timeframes.